Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma
Eligible Conditions
- Multiple Myeloma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Response Rate
Secondary outcome measures
Survival (overall and progression free)
toxicities
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
ZiopharmLead Sponsor
35 Previous Clinical Trials
3,986 Total Patients Enrolled
2 Trials studying Multiple Myeloma
47 Patients Enrolled for Multiple Myeloma
Alaunos TherapeuticsLead Sponsor
40 Previous Clinical Trials
4,382 Total Patients Enrolled
2 Trials studying Multiple Myeloma
47 Patients Enrolled for Multiple Myeloma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger